跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 620 条关于
“CG Invites”
全部
620
临床试验
432
药物
116
机构
7
资讯
65
去年
Huons Acquires 31.53% Stake in PanGen Biotech for $10.4 Million to Advance Biopharmaceutical CDMO Business
2年前
Cretostimogene Shows Promise in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
去年
CureGene's Novel Antiplatelet Therapy CG-0255 Receives Clinical Trial Approval in China
去年
CG Oncology's Bladder Cancer Drug Shows Promising Durability in Phase 3 Trial
8个月前
CG Oncology Accelerates PIVOT-006 Phase 3 Timeline for Bladder Cancer Treatment
去年
TARA-002 and Cretostimogene Grenadenorepvec Show Promise in Bladder Cancer
10个月前
CureGene's CG-0416 Shows Superior Fat Loss While Preserving Muscle in Preclinical Obesity Studies
去年
Cretostimogene Shows Durable Responses in High-Risk Bladder Cancer
去年
CG Oncology's Cretostimogene Shows Promise in Phase 3 Bladder Cancer Trial
28天前
CureGene Doses First Participant in Phase I Trial of Oral Liver-Targeting THR-β Agonist CG-0416
第 1 页,共 7 页
上一页
下一页